Progreso Quercus Competitors

Agriwise Finserv Limited is a Mumbai-based SI-NBFC registered with the RBI and a wholly owned subsidiary of StarAgri Group. We are committed to empowering MSMEs, farmers, and agri & allied entrepreneurs through innovative and customized financial solutions. Agriwise Finserve specialises in a wide range of products including Loan Against Property (LAP), Warehouse Receipt Finance (Commodity Finance), Invoice Bill Discounting (Supply Chain Finance), and Farmer Financing. Through our co-lending and business correspondent partnerships with leading banks and Financial Institutions, we deliver scalable credit solutions that fuel business growth and financial inclusion. We provide credit to farmers, input distributors & retailers, agri infrastructure or equipment providers, contract farmers, or any value-generating participant in the agri & MSME value chain. Our Loan Against Property (LAP) in India helps you unlock your property’s value and secure funding for multiple needs whether it’s a loan for business expansion, working capital, or capital investment. With deep roots in the agri ecosystem, Agriwise leverages technology platforms for loan origination, management, and risk assessment, ensuring faster turnaround, transparent processes, and customer satisfaction. Our focus is on building a healthy loan book, reducing NPAs, and strengthening India’s agri and MSME value chains. A simple three-step application process and 24-hour approvals make finance accessible without delay. At Agriwise, we are bridging the financing gap and driving sustainable growth – one entrepreneur, one farmer, and one business at a time.

Greenfield Partners was established by Eugene A. ("Gene") Gorab in 1997, and has since become one of the leading real estate investment managers in North America. Our firm manages capital on behalf of its Principals and Limited Partners and has, since inception, secured capital commitments in excess of $4.0 billion across a series of discretionary investment vehicles. Our Limited Partners include leading state and corporate pension plans, university endowments, private foundations and high net worth individuals. Greenfield is based in southwestern Connecticut with additional offices in Chicago, IL, and Arlington, VA. Our senior investment team averages 25 years of experience and our capabilities also encompass the related disciplines of development, tax, and finance. Our long-standing relationships provide a deep network of operating partners to draw upon such as property type experts and regionally focused sharpshooters. While, as a firm, we place tremendous emphasis on direct investment control, these partners expand our reach and allow us to better leverage the time and talent of our Principals.

BioHarvest Sciences Inc. (Nasdaq: BHST) is a public biotech company that has developed a patented Botanical Synthesis platform technology capable of growing the active and beneficial compounds in fruit & plants, at an industrial scale, without the need to grow the plant itself. BioHarvest has invested 17 years and >$100M to develop our Botanical Synthesis Technology, which produces unique and patentable botanical compositions which contain a “target optimized” combination of the phyto-medicinal compounds (with high solubility and bio-availability) found in the original plant. No other company has developed a commercially viable plant cell culture platform at the industrial scale of BioHarvest. BioHarvest is focused on leveraging this platform technology across the following business units: 1. Biologics+ CDMO Services: BioHarvest is leveraging its Botanical Synthesis technology to allow global pharmaceutical, nutrition, cosmetics, and nutraceutical partners to develop proprietary compounds with unmatched predictability and consistency, manufactured at industrial scale under exclusive partnerships. 2. Direct to Consumer Business Anchored in Science: BioHarvest has built its own direct to consumer business of propriety botanical compositions. The first product, VINIA® was launched into the US in 2021 and has now exceeded 60,000 daily users (>$50M USD Revenue since 2021 launch). VINIA® contains multiple polyphenols, including Piceid Resveratrol, with an amount in each daily 400mg capsule that is equivalent to 1,000 grapes, resulting in a powerful nutraceutical that has been clinically proven (in a published double-blind placebo-controlled study), to significantly increase dilation of arteries. This increased dilation of arteries improves blood flow and the delivery of oxygen and nutrients to the body, tissue & organs.